ArticleClinical and molecular hepatology2017
Epithelioid angiomyolipoma of the liver: a case report.
Article in Clinical and molecular hepatology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 22 citations in OpenAlex.
- Hepatic epithelioid angiomyolipoma treated with laparoscopic resection and transcatheter arterial embolization first time: A case report and review of literature.World journal of gastrointestinal surgery · 2026Article
- Case Report: Acquired CDKN2A/B deletion and mTOR inhibitor resistance in TSC2-mutant metastatic epithelioid angiomyolipoma.Frontiers in medicine · 2026Article
- Epithelioid angiomyolipoma of the liver in a patient with Li-Fraumeni syndrome: a case report.Diagnostic pathology · 2024Article
- Hepatic epithelioid angiomyolipoma: magnetic resonance imaging characteristics.Abdominal radiology (New York) · 2023Article
- Hepatic epithelioid angiomyolipoma is scattered and unsuitable for surgery: a case report.The Journal of international medical research · 2023Article
- Hepatic angiomyolipoma: A case report and literature review.International journal of surgery case reports · 2020Article
- Partial nephrectomy can be a successful treatment option for renal epithelioid angiomyolipoma: a case report and literature review.Acta medica Lituanic · 2020Article
- Two case reports and literature review for hepatic epithelioid angiomyolipoma: Pitfall of misdiagnosis.World journal of clinical cases · 2019Article
- Hepatic epithelioid angiomyolipoma with renal metastasis: radiologic-pathologic correlation.Radiology case reports · 2018Article
- Imaging appearance of renal epithelioid angiomyolipoma: A case report and literature review.Medicine · 2018Review
- Hepatic epithelioid angiomyolipoma: a report of two cases and review of the literature.International journal of clinical and experimental pathology · 2018Article
- Comparison of MRI Features of Epithelioid Hepatic Angiomyolipoma and Hepatocellular Carcinoma: Imaging Data From Two Centers.Frontiers in oncology · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Epithelioid angiomyolipoma (EAML) of liver is a rare neoplasm. Hepatic EAML is often misdiagnosed as other neoplasms such as hepatocellular carcinoma due to non-specific clinical and radiologic features. The morphologic features under microscope and immunohistochemistry staining profile are important in the diagnosis EAML. Here, we report a case of 52-year-old man who found 1.2 cm mass in liver by routine checkup. On the impression of hepatocellular carcinoma, lateral sectionectomy of the liver was done. Microscopically, the tumor is composed of predominant epithelioid cells with vascular component and foamy cells. These cells were positive for HMB45, MelanA, and smooth muscle actin and negative for epithelial membrane antigen. The final diagnosis was hepatic EAML.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.